e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Management, quality aspects and prognosis in thoracic oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are patients with malignant pleural effusions being referred appropriately for surgical intervention?
N. Acharya, M. Hewson (Carlisle, United Kingdom)
Source:
Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Session:
Management, quality aspects and prognosis in thoracic oncology
Session type:
E-Communication Session
Number:
1400
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Acharya, M. Hewson (Carlisle, United Kingdom). Are patients with malignant pleural effusions being referred appropriately for surgical intervention?. Eur Respir J 2008; 32: Suppl. 52, 1400
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Optimal management of symptomatic malignant pleural effusions: individualised care
Source: Virtual Congress 2021 – Hot news from the pleura
Year: 2021
Thoracoscopic palliative treatment of malignant pleural effusions
Source: Annual Congress 2011 - A little bit of everything: interventional pneumology
Year: 2011
Predictors of successful pleurodesis for patients with malignant pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 493s
Year: 2004
Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
The necessity of examination of patients with pleural effusions by oncological programme
Source: Eur Respir J 2006; 28: Suppl. 50, 75s
Year: 2006
Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009
How often is a single therapeutic aspiration sufficient to manage a malignant pleural effusion and does oncological treatment have an impact on this?
Source: International Congress 2019 – Pleural disease: applying the evidence
Year: 2019
ERS/EACTS statement on the management of malignant pleural effusions
Source: Eur Respir J, 52 (1) 1800349; 10.1183/13993003.00349-2018
Year: 2018
ERS/EACTS statement on the management of malignant pleural effusions
Source: Guideline 2018
Year: 2018
A Dutch web-survey on management of malignant pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011
The referral to diagnosis time for patients with malignant effusions presenting to a respiratory pleural clinic
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010
What is the optimal indication of thoracoscopy for pleural effusion in children?
Source: Eur Respir J 2003; 22: Suppl. 45, 319s
Year: 2003
Surgical problems with the malignant pleural space
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006
Management of recurrent transudative pleural effusions: can we REDUCE unnecessary interventions?
Source: Eur Respir J, 59 (2) 2101942; 10.1183/13993003.01942-2021
Year: 2022
The impact of multimodal treatment approaches in patients with malignant pleural mesothelioma
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010
Is prophylactic radiotherapy at intervention site always neccessary in malign pleural mesothelioma?
Source: Eur Respir J 2006; 28: Suppl. 50, 751s
Year: 2006
Closed percutaneous pleural brushing: a novel diagnostic approach for diagnosis of malignant pleural effusions
Source: Eur Respir J 2007; 30: Suppl. 51, 102s
Year: 2007
The importance of intrapleurally γ-interferon in ambulatory management of malignant pleural effusion in elderly patients with end-stage NSCCL
Source: Eur Respir J 2005; 26: Suppl. 49, 495s
Year: 2005
Role of medical thoracoscopy in diagnosis of recurrent undiagnosed pleural effusion
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept